A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2011
12/01/2011	US20110293663 Pharmaceutical botulinum toxin compositions
12/01/2011	US20110293662 Compositions comprising reduced genome bacteria for use in treatment of sepsis
12/01/2011	US20110293661 Vaccine strains of brachyspira hyodysenteriae
12/01/2011	US20110293660 Novel method
12/01/2011	US20110293659 Method for the oral/mucosal vaccination by means of recombinant yeasts
12/01/2011	US20110293658 Use of inkt or tlr agonists for protecting against or treating a disease such as acute infection or cancer
12/01/2011	US20110293657 Encapsulated vaccines for the oral vaccination and boostering of fish and other animals
12/01/2011	US20110293656 Recombinant mva capable of expressing structural hcv antigens
12/01/2011	US20110293655 Porcine Adenovirus 3-Based PRRSV Vaccines
12/01/2011	US20110293652 Chimeric ospa genes, proteins, and methods of use thereof
12/01/2011	US20110293651 HPV E6 protein T cell epitopes and uses thereof
12/01/2011	US20110293650 Influenza virus-like particles (vlps) comprising hemagglutinin
12/01/2011	US20110293649 In Vivo Activation of Antigen Presenting Cells for Enhancement of Immune Responses Induced by Virus Like Particles
12/01/2011	US20110293648 Ssx-2 peptides presented by hla class ii molecules
12/01/2011	US20110293647 Immunogenic lhrh compositions and methods relating thereto
12/01/2011	US20110293646 PAN-DR Binding Polypeptides and Uses Thereof
12/01/2011	US20110293645 Wdrpuh epitope peptides and vaccines containing the same
12/01/2011	US20110293644 Compositions and methods for treatment of celiac disease
12/01/2011	US20110293641 A vaccinia virus protein a46 peptide and use thereof
12/01/2011	US20110293640 Cholinesterase Inhibitors for Treating Inflammation
12/01/2011	US20110293639 Ideotypically modulated pharmacoeffectors for selective cell treatment
12/01/2011	US20110293638 Method to produce an immunoglobulin preparation with improved yield
12/01/2011	US20110293637 Compositions and methods of identifying tumor specific neoantigens
12/01/2011	US20110293636 Method for prongf assay for in vitro diagnosis of cancer in particular breast, thyroid or lung cancer and therapeutic use of prongf
12/01/2011	US20110293635 Composition and methods for modulating toll-like receptor activity
12/01/2011	US20110293634 Antibodies binding to adrenomedullin receptors and uses thereof as drugs
12/01/2011	US20110293633 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenic purpura (nait)
12/01/2011	US20110293632 Polypeptide variants with altered effector function
12/01/2011	US20110293631 Mast cell markers and prevention, diagnosis, and therapy for chronic pelvic pain syndrome
12/01/2011	US20110293630 Antibodies to Human GDF8
12/01/2011	US20110293629 Methods of Treating and/or Preventing Cell Proliferation Disorders with IL-17 Antagonists
12/01/2011	US20110293628 Pain treatment using erk2 inhibitors
12/01/2011	US20110293627 Combination therapy to enhance nk cell mediated cytotoxicity
12/01/2011	US20110293626 Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
12/01/2011	US20110293625 Inhibition of vegf-a secretion, angiogenesis and/or neoangiogenesis by sina mediated knockdown of vegf-c and rhoa
12/01/2011	US20110293624 Genes of an Otitis Media Isolate of NonTypeable Haemophilus Influenzae
12/01/2011	US20110293623 Antibodies as t cell receptor mimics, methods of production and uses thereof
12/01/2011	US20110293622 Antibodies to il-6 and use thereof
12/01/2011	US20110293621 Immunogenic polypeptides comprising a scaffold polypeptide and a l2 polypeptide or a fragment thereof
12/01/2011	US20110293620 Monoclonal Antibodies For Use In Diagnosis and Therapy of Cancers and Autoimmune Disease
12/01/2011	US20110293619 CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
12/01/2011	US20110293618 Anti-human clcp1 antibody and use thereof
12/01/2011	US20110293617 Anti-p-selectin antibodies and methods of their use and identification
12/01/2011	US20110293616 Antigen-presenting complex-binding compositions and uses thereof
12/01/2011	US20110293615 Use of Combination of Anti-Angiogenic Substance and c-kit Kinase Inhibitor
12/01/2011	US20110293614 Isoform specific anti-her4 antibodies
12/01/2011	US20110293613 Bispecific antibodies
12/01/2011	US20110293612 Method for the Treatment of Neurodegenerative Diseases
12/01/2011	US20110293611 Prevention of immunological rejection of transplanted stem cells by leukocyte costimulatory molecule blockade
12/01/2011	US20110293610 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
12/01/2011	US20110293609 Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
12/01/2011	US20110293608 Annexin a2 as immunological target
12/01/2011	US20110293607 Antibody Variants Having Modifications In The Constant Region
12/01/2011	US20110293606 Antitumor combinations containing antibodies recognizing specifically cd38 and vincristine
12/01/2011	US20110293605 Antibody formulation
12/01/2011	US20110293604 Polynucleotides and polypeptide sequences involved in the process of bone remodeling
12/01/2011	US20110293603 Amino acid sequences directed against multitarget scavenger receptors and polypeptides
12/01/2011	US20110293602 Vegf-like factor antibodies and methods of use thereof
12/01/2011	US20110293601 Composition and method for treatment of reperfusion injury and tissue damage
12/01/2011	US20110293600 Anticancer Composition Comprising Antitumor Agent and Substance Having Inhibitory Effects on L1CAM Activity and Expression
12/01/2011	US20110293599 Method for modulating muscle differentiation or regeneration
12/01/2011	US20110293598 Method to produce an immunoglobulin preparation with improved yield
12/01/2011	US20110293565 Novel synthetic agonists of tlr9
12/01/2011	US20110293564 2-morpholino-pyrido[3,2-d]pyrimidines
12/01/2011	US20110293561 Anti-kir combination treatments and methods
12/01/2011	US20110293560 Method for determining immune system activity and medicament for influencing same
12/01/2011	US20110293558 Material properties of t cells and related methods and compositions
12/01/2011	US20110293557 Conjugates for the administration of biologically active compounds
12/01/2011	US20110293526 Compositions and methods to modulate hair growth
12/01/2011	US20110293524 Methods and compositions for the regulation of lectin complement pathway (lcp)-associated complement activation in hyperglycemic myocardial damage
12/01/2011	US20110293521 Anti-viral compositions and methods for administration
12/01/2011	US20110293516 Compositions and methods of use of targeting peptides against placenta and adipose tissues
12/01/2011	US20110293514 Methods of using il-31 monoclonal antibodies to reduce inflammation
12/01/2011	US20110293513 Immunoconjugates with an Intracellularly-Cleavable Linkage
12/01/2011	US20110293512 Compositions and Methods for Inhibiting Growth of SMAD-4 Deficient Cancers
12/01/2011	US20110293511 Specific binding proteins and uses thereof
12/01/2011	CA2804119A1 Induced malignant stem cells or pre-induction cancer stem cells capable of self-replication outside of an organism, production method for same, and practical application for same
12/01/2011	CA2800785A1 Monoclonal antibodies against her2
12/01/2011	CA2800769A1 Monoclonal antibodies against her2 epitope
12/01/2011	CA2800734A1 Combination of anti-envelope antibodies and anti-receptor antibodies for the treatment and prevention of hcv infection
12/01/2011	CA2800581A1 Antibodies to human gdf8
12/01/2011	CA2800535A1 Class i mhc phosphopeptides for cancer immunotherapy and diagnosis
12/01/2011	CA2800488A1 Single -chain variable fragment anti-cd133 antibodies and uses thereof
12/01/2011	CA2800375A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
12/01/2011	CA2800188A1 Stable multi-dose compositions comprising an antibody and a preservative
12/01/2011	CA2800158A1 Vaccines comprising cholesterol and cpg as sole adjuvant-carrier molecules
12/01/2011	CA2799136A1 Vaccine against streptococcal infections based on recombinant proteins
12/01/2011	CA2798994A1 Multivalent synthetic nanocarrier vaccines
12/01/2011	CA2798739A1 Nanocarrier compositions with uncoupled adjuvant
12/01/2011	CA2798493A1 Synthetic nanocarrier combination vaccines
12/01/2011	CA2798323A1 Dose selection of adjuvanted synthetic nanocarriers
11/2011
11/30/2011	EP2390340A2 vector encoding Papillomavirus E1 and E2 polypeptides with reduced percentage of identity
11/30/2011	EP2390270A1 Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation
11/30/2011	EP2390269A1 Neoplasm specific antibodies and uses thereof
11/30/2011	EP2390268A1 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
11/30/2011	EP2390267A1 Stable and soluble antibodies inhibiting TNF(alpha)
11/30/2011	EP2390256A1 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
11/30/2011	EP2389954A1 Cytotoxic antibodies directed against factor VIII inhibitor antibodies
11/30/2011	EP2389953A1 Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist
11/30/2011	EP2389952A1 Lactadherin-derived peptides as antiviral agents

1 ... 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 ... 1823